Suppr超能文献

FBXO7(PARK15)缺失会导致蛋白酶体活性降低,并在小鼠中模拟出帕金森样表型。

Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.

作者信息

Vingill Siv, Brockelt David, Lancelin Camille, Tatenhorst Lars, Dontcheva Guergana, Preisinger Christian, Schwedhelm-Domeyer Nicola, Joseph Sabitha, Mitkovski Miso, Goebbels Sandra, Nave Klaus-Armin, Schulz Jörg B, Marquardt Till, Lingor Paul, Stegmüller Judith

机构信息

Cellular and Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany Neuroscience, International Max Planck Research School, Göttingen, Germany.

European Neuroscience Institute (ENI), Göttingen, Germany.

出版信息

EMBO J. 2016 Sep 15;35(18):2008-25. doi: 10.15252/embj.201593585. Epub 2016 Aug 5.

Abstract

Mutations in the FBXO7 (PARK15) gene have been implicated in a juvenile form of parkinsonism termed parkinsonian pyramidal syndrome (PPS), characterized by Parkinsonian symptoms and pyramidal tract signs. FBXO7 (F-box protein only 7) is a subunit of the SCF (SKP1/cullin-1/F-box protein) E3 ubiquitin ligase complex, but its relevance and function in neurons remain to be elucidated. Here, we report that the E3 ligase FBXO7-SCF binds to and ubiquitinates the proteasomal subunit PSMA2. In addition, we show that FBXO7 is a proteasome-associated protein involved in proteasome assembly. In FBXO7 knockout mice, we find reduced proteasome activity and early-onset motor deficits together with premature death. In addition, we demonstrate that NEX (neuronal helix-loop-helix protein-1)-Cre-induced deletion of the FBXO7 gene in forebrain neurons or the loss of FBXO7 in tyrosine hydroxylase (TH)-positive neurons results in motor defects, reminiscent of the phenotype in PARK15 patients. Taken together, our study establishes a vital role for FBXO7 in neurons, which is required for proper motor control and accentuates the importance of FBXO7 in proteasome function.

摘要

FBXO7(PARK15)基因突变与一种称为帕金森锥体综合征(PPS)的青少年型帕金森病有关,其特征为帕金森症状和锥体束征。FBXO7(仅含F-box结构域蛋白7)是SCF(SKP1/culin-1/F-box蛋白)E3泛素连接酶复合物的一个亚基,但其在神经元中的相关性和功能仍有待阐明。在此,我们报告E3连接酶FBXO7-SCF与蛋白酶体亚基PSMA2结合并使其泛素化。此外,我们表明FBXO7是一种参与蛋白酶体组装的蛋白酶体相关蛋白。在FBXO7基因敲除小鼠中,我们发现蛋白酶体活性降低、早发性运动缺陷以及过早死亡。此外,我们证明NEX(神经元螺旋-环-螺旋蛋白-1)-Cre诱导的前脑神经元中FBXO7基因缺失或酪氨酸羟化酶(TH)阳性神经元中FBXO7缺失会导致运动缺陷,这与PARK15患者的表型相似。综上所述,我们的研究确立了FBXO7在神经元中的重要作用,这对于正常运动控制是必需的,并突出了FBXO7在蛋白酶体功能中的重要性。

相似文献

1
Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
EMBO J. 2016 Sep 15;35(18):2008-25. doi: 10.15252/embj.201593585. Epub 2016 Aug 5.
3
4
The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129754. doi: 10.1016/j.bbagen.2020.129754. Epub 2020 Sep 30.
5
A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function.
FEBS J. 2024 Jun;291(12):2562-2564. doi: 10.1111/febs.17155. Epub 2024 May 6.
6
Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
Curr Protein Pept Sci. 2017;18(7):715-724. doi: 10.2174/1389203717666160311121433.
7
Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice.
Mol Brain. 2022 Jun 14;15(1):54. doi: 10.1186/s13041-022-00936-5.
9
Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Biochem J. 2016 Oct 15;473(20):3563-3580. doi: 10.1042/BCJ20160387. Epub 2016 Aug 8.
10
Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria.
FEBS J. 2024 Jun;291(12):2565-2589. doi: 10.1111/febs.17114. Epub 2024 Mar 11.

引用本文的文献

2
FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma.
Nat Commun. 2024 Jun 5;15(1):4790. doi: 10.1038/s41467-024-49087-2.
3
USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
PLoS One. 2023 Oct 24;18(10):e0290371. doi: 10.1371/journal.pone.0290371. eCollection 2023.
4
FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.
Adv Sci (Weinh). 2023 Nov;10(33):e2303561. doi: 10.1002/advs.202303561. Epub 2023 Oct 11.
5
PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems.
EMBO Rep. 2023 Aug 3;24(8):e56399. doi: 10.15252/embr.202256399. Epub 2023 Jun 19.
6
Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder.
Int J Mol Sci. 2023 May 12;24(10):8672. doi: 10.3390/ijms24108672.
7
Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons.
Antioxidants (Basel). 2023 Jan 10;12(1):164. doi: 10.3390/antiox12010164.
8
The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.
Mol Neurobiol. 2023 Jan;60(1):247-263. doi: 10.1007/s12035-022-03063-3. Epub 2022 Oct 19.
9
Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice.
Mol Brain. 2022 Jun 14;15(1):54. doi: 10.1186/s13041-022-00936-5.
10
FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity.
J Biol Chem. 2021 Dec;297(6):101426. doi: 10.1016/j.jbc.2021.101426. Epub 2021 Nov 17.

本文引用的文献

2
A new F-box protein 7 gene mutation causing typical Parkinson's disease.
Mov Disord. 2015 Jul;30(8):1130-3. doi: 10.1002/mds.26266. Epub 2015 May 23.
4
Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.
Mol Cell. 2015 Mar 19;57(6):1022-1033. doi: 10.1016/j.molcel.2015.01.015. Epub 2015 Feb 26.
6
FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family.
Parkinsonism Relat Disord. 2014 Nov;20(11):1253-6. doi: 10.1016/j.parkreldis.2014.07.016. Epub 2014 Aug 14.
7
A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism.
Parkinsonism Relat Disord. 2014 Nov;20(11):1248-52. doi: 10.1016/j.parkreldis.2014.06.024. Epub 2014 Jul 22.
8
Lysine ubiquitination and acetylation of human cardiac 20S proteasomes.
Proteomics Clin Appl. 2014 Aug;8(7-8):590-594. doi: 10.1002/prca.201400029.
9
Reversible 26S proteasome disassembly upon mitochondrial stress.
Cell Rep. 2014 Jun 12;7(5):1371-1380. doi: 10.1016/j.celrep.2014.04.030. Epub 2014 May 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验